Author(s): Feldman BJ, Feldman D, Feldman BJ, Feldman D
Abstract Share this page
Abstract The normal prostate and early-stage prostate cancers depend on androgens for growth and survival, and androgen ablation therapy causes them to regress. Cancers that are not cured by surgery eventually become androgen independent, rendering anti-androgen therapy ineffective. But how does androgen independence arise? We predict that understanding the pathways that lead to the development of androgen-independent prostate cancer will pave the way to effective therapies for these, at present, untreatable cancers.
This article was published in Nat Rev Cancer
and referenced in Journal of Cancer Science & Therapy